Pharmacogenetics in immunosuppressive therapy: The best thing since TDM?

2004-08-01

Therapeutic Drug Monitoring , Volume 26 - Issue 4 p. 343- 346

Additional Metadata
Keywords	Immunosuppressive therapy, Pharmacogenetics, TDM
Persistent URL	doi.org/10.1097/00007691-200408000-00001, hdl.handle.net/1765/59675
Journal	Therapeutic Drug Monitoring
Organisation	Department of Clinical Chemistry
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Gelder, T., Hesselink, D., van Hest, R., Mathot, R., & van Schaik, R. (2004). Pharmacogenetics in immunosuppressive therapy: The best thing since TDM?. Therapeutic Drug Monitoring, 26(4), 343–346. doi:10.1097/00007691-200408000-00001

Publication